Products & Features
Minimally invasive solutions in the field of cardiology
Having more than 25 years of experience in the medical field, P+F’s leadership team has built up a complete research, development, manufacture and distribution infrastructure to deliver significant innovations and add economic value to its customers.
P+F is headquartered in Vienna, Austria, and has operation facilities in Germany, Portugal, Spain and Brazil.
TricValve® transcatheter bicaval valves are a system of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux.
The prostheses are implanted percutaneously into the superior and inferior vena cava without disturbing the native tricuspid valve. They are especially intended for use in patients at extreme risk or who are inoperable for traditional heart surgery.
The Vienna aortic self-expandable transcatheter valve is designed to treat severe aortic stenosis in patients at medium to high risk for open heart surgery.
The minimally invasive heart valve replaces the native valve without the need for concomitant surgical removal and is placed via femoral access. The new generation device comes fully premounted with specially prepared bovine pericardium, thus reducing preparation steps and procedure time.
